ClinicalTrials.Veeva

Menu

Migraine Treatment in ED

NYU Langone Health logo

NYU Langone Health

Status

Withdrawn

Conditions

Migraine

Treatments

Drug: Topiramate
Drug: Abortive Medication (Naproxen and Sumatriptan)
Behavioral: Relaxation Therapy
Drug: Standard of Care

Study type

Interventional

Funder types

Other

Identifiers

NCT02643719
14-01981

Details and patient eligibility

About

Randomized pilot feasibility study evaluating the impact of introducing behavioral treatment for migraine in the Emergency Department (ED) and prescribing migraine preventive medications in the ED. The study will examine the effect of these treatments, both individually and in combination, on pain severity and headache-related disability. This study is designed to examine the feasibility of comparing four interventions for ED patients presenting with migraine. Group 1: Starting topiramate; Group 2: Doing a brief behavioral intervention; Group 3: Treating with combination therapy of topiramate and behavioral intervention; and Group 4: Standard of Care.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18 years to 65 years of age
  • primary diagnosis of migraine based on the International Classification of headache disorders 3 beta criteria
  • having a migraine 3 or more days/month.

Exclusion criteria

  • Cognitive Behavioral Therapy (CBT), biofeedback or other relaxation therapy in the past year
  • being on medication used for migraine prevention (topiramate, propranolol, valproic acid, amitriptyline/nortriptyline/imipramine/desipramine, botulinum toxin, a SNRI, angiotensin-converting enzyme inhibitors (ACE-I) or ARB)
  • cognitive deficit or other physical problem with the potential to interfere with behavioral therapy
  • substance or alcohol abuse as determined by self-report or prior documentation in the medical record.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 4 patient groups

Topiramate
Active Comparator group
Treatment:
Drug: Topiramate
Drug: Abortive Medication (Naproxen and Sumatriptan)
Behavioral intervention
Active Comparator group
Treatment:
Drug: Abortive Medication (Naproxen and Sumatriptan)
Behavioral: Relaxation Therapy
topiramate and behavioral intervention
Active Comparator group
Treatment:
Drug: Topiramate
Drug: Abortive Medication (Naproxen and Sumatriptan)
Behavioral: Relaxation Therapy
Standard of Care
Active Comparator group
Treatment:
Drug: Standard of Care
Drug: Abortive Medication (Naproxen and Sumatriptan)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems